The notable progress in laser particle acceleration technology promises potential medical application in cancer therapy through compact and cost effective laser devices that are suitable for already existing clinics. Previously, consequences on the radiobiological response by laser driven particle beams characterised by an ultra high peak dose rate have to be investigated. Therefore, tumour and non-malignant cells were irradiated with pulsed laser accelerated electrons at the JETI facility for the comparison with continuous electrons of a conventional therapy LINAC. Dose response curves were measured for the biological endpoints clonogenic survival and residual DNA double strand breaks. The overall results show no significant differences in radiobiological response for in vitro cell experiments between laser accelerated pulsed and clinical used electron beams. These first systematic in vitro cell response studies with precise dosimetry to laser driven electron beams represent a first step toward the long term aim of the application of laser accelerated particles in radiotherapy.
INTRODUCTION
Until now ion radiotherapy including protons and heavier particles is limited to a few large scale facilities, e.g. HIT or NIRS, due to the requirement of a synchrotron or cyclotron accelerator often associated with large gantry systems. 1, 2) The development of high intensity laser particle acceleration over recent years has been discussed as a potential alternative acceleration technology for ion radiotherapy. [3] [4] [5] [6] [7] [8] The laser particle acceleration (cf. Fig. 1 ) was firstly proposed theoretically for electrons 9) and has rapidly progressed to the generation of intense electron [10] [11] [12] [13] and ion pulses. [14] [15] [16] Several studies have been published demonstrating simulations and proposals of laser particle acceleration improvements as well as the essential beam transport for the therapeutic application. 3, [17] [18] [19] [20] [21] [22] [23] As consequence the laser plasma community is promising compact and potentially very cost effective laser facilities [4] [5] [6] [7] [24] [25] [26] [27] that are suitable for already existing clinics. Among others the specific property of laser accelerated particle beams is the ultra high pulse dose rate (≥ 10 9 Gy/sec) exceeding those of conventional accelerated particle beams by several orders of magnitude. [28] [29] [30] [31] Before clinical application several strict requirements with respect to beam parameters like dose rate, particle energy, stability, quality assurance and patient safety need to be fulfilled. 5, 6, 27, 32) Moreover, the physical and real-time dosimetric characterization and the investigation of radiobiological consequences of novel laser accelerated particle beams are essential. These imply complex translational investigations starting from in vitro cell irradiation to animal experiments and finally clinical trials with patients.
Even though the development of laser driven proton and ion therapy is the long term goal, the first laser accelerated particles being experimentally available with sufficient high energy and intensity as well as high pulse frequency relevant for radiotherapeutic application are laser accelerated electrons. Accordingly, laser accelerated electrons produced at the JETI laser facility in Jena were used for the experiments presented here. Beyreuther et al. 28) have shown the general applicability of the JETI system for in vitro cell experimentation. The aim of the present study was to determine dose response curves and to compare the radiobiological effectiveness of laser generated electron pulses with that of a continuous beam delivered by a clinical LINAC for both non-malignant and tumour cells.
MATERIALS AND METHODS

Cell lines and cell culture
The undifferentiated human squamous cell carcinoma FaDu, 33, 34) established as subline of the original FaDu cell line, 35) was maintained in Dulbecco's minimum essential medium with 4.5 g/l stable glutamin (Biochrom, Berlin, Germany) containing 10% FBS (Sigma-Aldrich, Munich, Germany), 1 mM sodium pyruvate, 20 mM HEPES, 1% 100x non-essential amino acids (all from PAA, Pasching, Austria) and 1% Penicillin/Streptomycin (Biochrom). The non-malignant, immortalised, normal mammary gland epithelium cell line 184A1 (CRL-8798, ATCC, LGC Promochem, Wesel, Germany), originally established from a mammoplasty, 36) was grown in serum-free mammary epithelial basal medium supplemented with MEGM SingleQuots ® (both from Lonza, Cologne, Germany), 50 mg/ml prostaglandin E1 (Calbiochem, Darmstadt, Germany) and 5 μg/ml human apotransferrin (Sigma-Aldrich). Both cell cultures were maintained at 37°C, 5% CO2, 95% humidification and routinely checked for mycoplasma using Venor ® GeM (Biochrom). Exponentially growing cells were seeded two days before irradiation in 8-well-chamber-slides (Permanox TM , Nunc, Wiesbaden, Germany) for γH2AX/53BP1 assay at a density of 2.5 × 10 4 cells/cm 2 and for clonogenic assay in 35 mm petri dishes (Greiner bio one, Frickenhausen, Germany) at a density of 1.0 × 10 5 cells/cm 2 . One day before irradiation, the cell culture medium was completely exchanged. Immediately before irradiation the cell samples were completely filled up with culture medium and finally closed with sterile Parafilm ® (24 h in 80% Ethanol, at least 2 h UV light). The cell vitality and plating efficiency under these conditions was constant over the tested period up to 4 hours. Unirradiated cell samples were prepared in the same way like the irradiated probes and were used as controls.
Irradiation with laser accelerated electrons at JETI
Customation of the Jena Titanium:Sapphire laser system (JETI) for irradiation of cells was previously described. 28) The further optimized setup used for the experiments reported here is shown in Fig. 2 . Two basic improvements were introduced: a more effective filtering of low energetic electrons by a permanent S-bending magnetic energy filter with 0.12 T and the control of the electron energy distribution. The energy spectrum was controlled directly with an electromagnetic spectrometer detecting the intensities of the deflected electrons with Gafchromic™ EBT-1 radiochromic films (ISP Corp., Wayne, USA) or imaging plates (Fujifilm, Tokio, Japan). Additionally, the spectrum was reconstructed on basis of depth dose distributions that were measured on a daily basis with EBT-1 film stacks. The obtained energy spectra were in good agreement to each other, covering an energy range of 3-20 MeV and showing a maximum of the energy spectrum at approximately 6.5 MeV. 37) Online monitoring and irradiation control were performed with a Roos ionization chamber type 34001 (PTW, Freiburg, Germany) and a Faraday cup (manufactured in house) both providing real-time dose information. Additionally, EBT-1 films were placed in front of each cell sample to determine retrospectively the absolute dose delivered to the cells. In order to correct the dose differences between the film location in front of the cell culture vessel and at the cell monolayer location, a mean dose correction factor of 1.064 was determined by averaging the dose ratios obtained on a daily basis for the two vessel types with films at both positions. At this, water equivalent material RW3 (PTW) was placed directly behind the film at cell position to account for backscattered electrons from the cell media.
For cell irradiation each sample was placed in a PMMA sample holder and was set with the vessel bottom facing to the horizontal beam coming from direction of the vacuum window minimizing the material in front of the cell monolayer (cf. Fig. 2) . Doses in the range of 0.4 Gy to 10.2 Gy were delivered to the cells by 125 to 4900 electron pulses with a repetition rate of 2.5 Hz. A peak dose rate of 2.4 × 10 9 Gy/sec was supposed by the estimated pulse duration of 1 × 10 -12 sec based on laser pulse length, acceleration process and electron beam transport. In spite of the ultra high peak dose rate a rather low mean dose rate of (0.361 ± 0.013) Gy/min while irradiation time, averaged over all 163 cell irradiation, was determined. This was a substantial improvement compared to the 0.24 Gy/min achieved previously. 28) Nevertheless the practically obtained still low mean dose rate is the result of the limit with the current laser system and of the complex optimization of the necessary beam parameters for cell irradiation like dose homogeneity, beam stability, reproducibility, intensity and spot size.
Irradiation using a clinical electron linear accelerator
A clinical electron linear accelerator (LINAC, Oncor Impression, Siemens AG, Healthcare, Erlangen, Germany) located in Dresden was used for in vitro cell irradiation. The LINAC was calibrated using the TRS-398 dosimetry protocol.
38) The electron beam of the clinical setting was delivered with a dose rate of 3 Gy/min, whereas the energy of 6 MeV was chosen in accordance to the maximum of the energy spectrum generated by the JETI laser accelerator facility. It has to be noted that the LINAC electron beam is also a pulsed beam. The beam was delivered with pulse duration of 4 μsec at a pulse frequency of 50 Hz which results in a duty cycle of 2 × 10 -4 . In comparison to the duty cycle of 2.5 × 10 -12 of the laser electron beam, the LINAC electron beam is considered in the following text as continuous beam.
Both vessel types were irradiated in horizontal position with the beam coming from above entering the cell monolayer through the top of the petri dish or the bottom of the 8-well-chamber-slide. In order to position the cell monolayer at the reference depth, the vessels were covered by PMMA slabs of 10 mm and 2 mm for the 8-well-chamber-slides and petri dishes, respectively. To ensure charged particle equilibrium in the whole vessel, the vessel was surrounded by RW3 (PTW).
X-ray reference irradiation
Two independent electron irradiation experiments were performed at the JETI laser facility in Jena and at the clinical therapy LINAC in Dresden. In order to investigate possible diversities of cell cultivation and distinct radiosensitivity Xray reference irradiation has been performed in parallel to each electron experiment. Dose response curves were determined for each biological endpoint at the two 200 kVp X-ray tubes -Maxishot 200 Y.TU/320-D03 (Yxlon International A/S, Taastrup, Denmark) in Jena and Isovolt 320/20 (Röntgen Seifert, Ahrensburg, Germany) in Dresden -with similar radiation quality, respectively. Characteristics of both tubes and absolute dosimetry under consideration of the different irradiation geometries were previously described. 
Fig. 2.
Experimental setup of the laser accelerator JETI: Laser pulses were focused into a helium gas jet. During the interaction, the laser pulse generates plasma and accelerates electrons in forward direction. The electrons were energetically filtered by a pair of permanent magnets and exited the vacuum system through a 1 mm thin aluminium window. Behind this filter arrangement, the electron beam propagates in air and passes the cell monolayer sample (diameter of 35 mm). For relative online dosimetry an ionization chamber and a Faraday cup were used. Radiochromic films allowed an absolute dosimetric determination directly at cell position. The spectrometer, image plates and radiochromic films were used to determine the energy spectrum. Thus, by a focus-to-object distance of 464 mm a dose rate of 1.39 Gy/min for the Yxlon tube and a dose rate of 1.21 Gy/min at a focus-to-object distance of 460 mm for the Isovolt tube were determined, respectively. Dose homogeneity over the irradiated field was controlled with EBT-1 films. 41) At both X-ray tubes, the cell samples were placed on a horizontal PMMA holder and were irradiated at room temperature from above.
The X-ray reference irradiation performed in Dresden and Jena were used in order to consider different cell conditions at the two experimental sites by introducing a scaling factor. This includes all factors (e.g. from laboratory equipment such as incubator or reported in 42) ) which influence the dose response curve but could not be reflected by the subtraction of the background level of the unirradiated control samples. The scaling factor was calculated by the ratio between the slopes of the two X-ray dose response curves, i.e. the curve determined in Dresden and Jena, respectively. For cell survival, both cell lines showed no significant difference between the X-ray dose response curves under consideration of their 95% confidence interval and correspondingly the scaling factor was 1. The scaling factor was used to adapt the LINAC (Dresden) electron dose response curve for comparison with the JETI (Jena) electron dose response curve. The resulting data were fitted in a multilevel fit as described below. Uncertainties by using the scaling factors have been considered by error propagation.
In order to quantify the effect due to low mean dose rate of laser electrons a low dose rate X-ray irradiation (0.35 Gy/min, 5 mA, LDR) was performed in addition to the usually utilized dose rate (1.39 Gy/min, 20 mA, HDR).
Colony forming assay
Cell survival was determined by standard colony forming assay. Immediately after irradiation the cells were rinsed, trypsinised and seeded as duplicates for each dose point in 6 different concentrations using 6-well-plates (Greiner bio one). The cells were incubated for 13 days (37°C, 5% CO2, 95% humidity), fixed for 15 min with ice cold 80% ethanol and stained for 10 min with crystal violet (Clin-Tec, Munich, Germany). Colonies of more than 50 cells were considered as survivors.
Immunohistochemistry
Residual DNA double strand breaks (DSB) were detected immunohistochemically by the γH2AX/53BP1 technique, as previously described. 34, 40) Irradiated cells were incubated (24 h, 37°C, 5% CO2, 95% humidity) and accordingly fixed in natural buffered 1% formalin (15 min), washed once with PBS/Glycine (Merck, Darmstadt, Germany) and permeabilised with ice cold triton X-100 solution (5 min, 3x, 0.01% in PBS, BDH Biochemicals, Dorset, England). Subsequently, the cells were washed in PBGT solution consisting of 0.5% gelatine (BDH Prolabo ® ) and 0.025% TWEEN ® 20
(Sigma-Aldrich) in PBS and sequently stained with antiphospho-Histone H2AX (1:1000 in PBGT, 1 h, upstate by millipore, Schwalbach, Germany), Alexa Fluor ® 594 goat anti-mouse IgG (1:400 in PBGT, 30 min, Invitrogen, Karlsruhe, Germany), anti-53BP1 (1:3000 in PBGT, 1 h, Novus Biologicals, Littleton, USA) and Alexa Fluor ® 488 goat anti-rabbit IgG (1:1000 in PBGT, 30 min, Invitrogen). The incubation was performed at 37°C in a wet chamber. After each staining step the cells were washed with PBGT (5 min, 3x) . Finally, the cell samples were mounted with DAPI/Vectashield mounting medium (Vector Laboratories, Burlingame, USA) and capped with a coverslip. The γH2AX/53BP1 foci were counted visually under 1000-fold magnification using an Axiovert S100 fluorescence microscope (Carl Zeiss, Jena, Germany) and the HC TriplebandFilterset DAPI/FITC/TxRED (AHF Analysentechnik, Tübingen, Germany). For each dose point 100 randomly chosen intact nuclei, which was controlled by DAPI staining, were analysed.
Statistical Analysis
The dose dependent surviving fractions (SF) were determined for two to three independent experiments for all radiation qualities and cell lines. All dose response curves were fitted by the software Origin 8 (OriginLab Corporation, Northampton, USA) in a multilevel fit considering both the uncertainties in dose and in the corresponding biological endpoints. Figure 3 compares the cell survival curves achieved by irradiating the two cell lines (184A1, FaDu) with laser accelerated electrons of ultra high peak dose rate but low mean dose rate and continuous, clinical used LINAC electrons. The associated survival dose response curves to the 200 kVp X-ray reference irradiation at each experimental site were consistent for both cell lines allowing the direct comparison of the two electron dose response curves without applying a scaling factor. No significant difference in absolute cell survival level was determined between the radiobiological dose responses to both electron beams. But the shape of the two survival curves caused by both electron beam qualities dif-fers slightly.
RESULTS
The variation in the shape of survival curves caused by the low mean dose rate of JETI laser electrons affirm the well known dose rate effect. A clear modification in the shape of the survival curve was determined for the irradiation of 184A1 with JETI electrons. The low mean dose rate reduced the shoulder of the survival curve as seen for the red line and became more similar to a straight line than the blue one on the log-linear diagram. With the FaDu cells this effect was less obvious. For affirmation of the observed mean dose rate effect in vitro cell experiments were performed with 200 kVp X-ray reference irradiation using the low dose rate, equal to JETI electrons, in comparison to the conventional dose rate of clinical used LINAC electrons. Figure 4 presents the survival curves determined for both dose rate regimes for 184A1 and FaDu. All over again in both cell lines as expected the grey lines, low dose rate, showed a less expressed shoulder and are therefore more similar to a straight line than the black ones representing the usually used dose rate. The coefficients derived from the fitting procedure are presented in Table 1 together with their standard errors and coefficients of determination R 2 . For residual DNA DSB 24 h after irradiation, as second radiobiological endpoint, a difference in dose response curves was obtained for both cell lines by analysing the Xray reference irradiation data in Jena and Dresden. The investigation of residual DNA DSB was more sensitive e.g. Table 1 . Coefficients and standard error (SE) of the linearquadratic model for the survival curves presented in Fig. 3 und Fig. 4 as well as the coefficients of determination R 2 of the curves.
Cell line Radiation quality α (Gy to cell culture conditions at each experimental site compared to the cell survival and consequently the scaling of the DNA DSB data was necessary. Hence, the LINAC electron data were scaled in order to compare with the JETI electron data.
Referring to this the corresponding γH2AX/53BP1 foci regression data before and after scaling were summarised in Table 2 . In addition, the mean background levels of γH2AX/ 53BP1 foci for both cell lines depending on the experiment location are listed in Table 3 . Figure 5 presents the dose response curves of residual DNA DSB determined by JETI laser electrons with an ultra high peak dose rate but low mean dose rate and by clinical used LINAC electrons after scaling. A reduced biological effectiveness was obtained for 184A1 cells to laser accelerated electrons compared to clinical used LINAC electrons. But for FaDu cells again no significant difference was determined for the value of residual DNA DSB caused by the two electron beams just as seen for cell survival for both cell lines. The investigation of the mean dose rate effect with 200 kVp X-ray reference irradiation for both dose rate regimes resulted in no significant difference in the shape of the dose response curves as well as in the number of residual γH2AX/53BP1 foci.
The homogeneity and stability of dose delivery by the laser electron beam was important to guarantee the quality of the radiobiological results in the present work. For the target areas of the two sample geometries, vessels for cell survival and γH2AX/53BP1 foci, an overall inhomogeneity of less than 10% was revealed by means of EBT-1 films for all days and all applied doses. Hence, we could be ensuring that all cells in each vessel got the same dose and therewith the radiobiological analyses were well-defined. The accurate correlation between online and absolute dosimetry as well as the securing of the correct energy filtering and the control of the shot-to-shot dose fluctuations have been presented previously.
37) The inter-day dose rate reproducibility and stability of the laser accelerated electron beam over the whole cell irradiation campaign is depicted in Fig. 6 .
DISCUSSION
The data reported here represent the worldwide first systematic irradiation experiments with normal tissue and tumour cells using ultra short pulsed laser accelerated electron beams for a comparison with a conventional therapeutic beam. The JETI laser facility satisfied the basic technical requirements for radiobiological experiments like beam reproducibility, stability and reliability of performance over long times. 28, 37, 43) The available energy of the laser accelerated electrons was already of therapeutic relevance and consequently that electron beam was chosen for the presented investigation. In order to study the influence of the specific properties of the novel laser acceleration technology, the delivery of ultra high peak dose rate due to short pulse duration combined with very high pulse dose, dose response curves for two cell lines and two biological endpoints were investigated. Only in case of 184A1 a reduced biological effectiveness on DNA DSB for pulsed laser electrons relative to continuous LINAC electrons was determined. In all other cases, i.e. cell survival for both cell lines and DNA DSB for FaDu cells, the dose response curves showed no significant differences in radiobiological effectiveness between laser accelerated electron beam with an ultra high peak dose rate and continuous, clinical used LINAC electron beam.
In order to estimate the influence of the specific very high peak dose rate of laser accelerated electron beams all other physical and radiobiological influence factors, like the cell biological diversity, the energy spectrum with the corresponding LET (linear energy transfer) values and the mean dose rate of the electron beam had to be excluded or quantified.
The influence of the experimental diversities arising from different cell culture conditions in the two laboratories were cancelled out. The non-radiation induced biological effects, exemplified by the different background level of γH2AX/ 53BP1 foci (cf. Table 3) , were eliminated by subtraction of the background levels of the unirradiated control samples. Moreover, influences which cannot be taken into account by unirradiated controls have been considered by scaling of the results using the radiobiological responses of the corresponding 200 kVp X-ray reference irradiation at the two sites.
To estimate whether the observed difference between DNA DSB and cell survival in cell line 184A1 is due to method of γH2AX/53BP1 foci analysis it has to be mentioned that there are several strength and weakness concerning the immunofluorescence staining techniques. 42, 44, 45) However, all factors should be equal between the experiments performed in Jena and Dresden. Therefore we can exclude that our method of γH2AX/53BP1 foci analysis caused the observed reduced biological effectiveness of 184A1 for DNA DSB comparing laser electrons with clinical used electrons.
An influence of the electron spectrum on the results was minimized by filtering out the biological more effective low energy JETI electrons. The filtering resulted in a broad, but downwards limited, JETI electron spectrum of 3-20 MeV, 37) which is characterised by a constant RBE value. 46) Furthermore, the clinical used 6 MeV LINAC electrons were in accordance to the maximum of the energy spectrum of 6.5 MeV of the JETI electrons. Therefore, the influence of the electron energy spectrum was negligible.
The expected influence of the low mean dose rate with 0.35 Gy/min of the JETI electron beam was ascertained. This mean dose rate lies within the limits of 0.01 Gy/min to 1 Gy/min, a region where the effects of DNA damage repair, cell cycle progression and repopulation on the radiobiological effect (i.e. its decreasing) are most pronounced. [47] [48] [49] [50] This aspect was studied in detail with 200 kVp X-ray irradiation performed with low dose rate, equal to JETI electrons, compared to conventional dose rate of the LINAC electrons. For cell survival the modification in the shape of the JETI electron dose response curve to a straight line due to the less expressed shoulder was confirmed by the 200 kVp X-rays. This indicated the dose rate effect by low mean dose rate irradiation which exactly would be expected if there is an increasing contribution by sublethal damage repair, which already takes place during the radiation exposure. For residual DNA DSB no significant difference in the shape of the dose response curves as well as in the mean number of residual DNA DSB was determined for both cell lines (data not presented). Thus, the observed reduced biological effectiveness of laser electrons compared to clinical used electrons in the case of 184A1 γH2AX/53BP1 foci is not a result of the low dose rate effect.
In consequence of the characterisation of the discussed physical and radiobiological parameters the influence of the ultra high peak dose rate of laser accelerated electron beam could be investigated. In the present investigation no significant differences were obtained for comparison of the radiobiological responses due to laser electrons versus clinical used electrons with the only exception of 184A1 DNA DSB analysis. Up to now there were no further data for systematic radiobiological cell responses with precise dosimetry to laser accelerated electron beams as presented here. In previous studies the issue of different time structures of dose delivery, especially the ultra high pulse dose rate, which might result in different radiobiological responses, were analysed. [51] [52] [53] [54] [55] [56] Referring to this, studies were performed for clonogenic survival and γH2AX foci for ultra short pulsed photons delivered by a laser accelerated plasma X-ray source with dose rates of up to 10 11 Gy/min relative to a conventional photon source, in which no difference was obtained. [51] [52] [53] Analysing clonogenic survival following ultra short pulsed or continuous electron irradiation of conventional radiation sources with single or few nanosecond electron pulses indicates again no significant difference. 54, 55) Currently, in vitro studies are performed at the electron beam of the experimental radiation source ELBE (Electron LINAC for beams with high Brilliance and low Emittance), 57) which mimic both the ultra high pulse dose rate of the laser electron beam and the conventional pulsed dose rate delivered by a LINAC. Our first preliminary data indicate no significant difference in dose responses between ultra high pulse dose rate and clinical used dose rate. 58) These experimental series as well as the previous studies on conventional radiation sources confirmed our results that there was no systematic difference between ultra short pulsed JETI laser electrons and clinical used LINAC electrons.
The next step in the translational chain includes in vivo responses to laser accelerated electron beams. Moreover, the rapid progress in laser technology with increasing the laser power allows to extent experiments to laser accelerated pro-ton beams. By using the new laser system DRACO that provides more than 10 times higher laser power compared to the actual used JETI laser system allows the acceleration of protons up to 20 MeV for radiobiological experiments. 30) First in vitro cell irradiation experiments have also been performed recently at the J-KAREN laser system with proton energies up to 2.4 MeV.
31)
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